Novo Nordisk's long-acting growth hormone has been approved in China
Novo Nordisk's long-acting growth hormone has been approved in China Novo Nordisk's long-acting growth hormone (brand name: Sogroya®/Somapacitan injection) has been approved in China for the treatment






